JPS6223723B2 - - Google Patents

Info

Publication number
JPS6223723B2
JPS6223723B2 JP53035834A JP3583478A JPS6223723B2 JP S6223723 B2 JPS6223723 B2 JP S6223723B2 JP 53035834 A JP53035834 A JP 53035834A JP 3583478 A JP3583478 A JP 3583478A JP S6223723 B2 JPS6223723 B2 JP S6223723B2
Authority
JP
Japan
Prior art keywords
fluorouracil
compound
antitumor
fluorouracils
antitumor effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53035834A
Other languages
English (en)
Japanese (ja)
Other versions
JPS54129131A (en
Inventor
Setsuo Fujii
Norio Saimi
Setsuo Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP3583478A priority Critical patent/JPS54129131A/ja
Priority to GB7908960A priority patent/GB2016921B/en
Priority to AU45196/79A priority patent/AU520060B2/en
Priority to CH272679A priority patent/CH639274A5/de
Priority to FR7907523A priority patent/FR2420974A1/fr
Priority to IT67629/79A priority patent/IT1119283B/it
Priority to DE2912112A priority patent/DE2912112C2/de
Publication of JPS54129131A publication Critical patent/JPS54129131A/ja
Priority to US06/552,263 priority patent/US4650801A/en
Priority to US06/932,516 priority patent/US4914105A/en
Publication of JPS6223723B2 publication Critical patent/JPS6223723B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP3583478A 1978-03-27 1978-03-27 Antiimalignant tumor agent composition Granted JPS54129131A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP3583478A JPS54129131A (en) 1978-03-27 1978-03-27 Antiimalignant tumor agent composition
GB7908960A GB2016921B (en) 1978-03-27 1979-03-14 Anti cancer compositions containing uracil derivatives
AU45196/79A AU520060B2 (en) 1978-03-27 1979-03-16 5-fluorouracil anticancer compositions
CH272679A CH639274A5 (de) 1978-03-27 1979-03-23 Antikrebsmittel.
FR7907523A FR2420974A1 (fr) 1978-03-27 1979-03-26 Medicament a base de derives de l'uracile
IT67629/79A IT1119283B (it) 1978-03-27 1979-03-27 Composizione anti cancro
DE2912112A DE2912112C2 (de) 1978-03-27 1979-03-27 Antikrebs-Präparat
US06/552,263 US4650801A (en) 1978-03-27 1983-11-16 Anti-cancer compositions for delivering 5-fluorouracil
US06/932,516 US4914105A (en) 1978-03-27 1986-11-20 Anti-cancer compositions for delivering 5-fluorouracil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3583478A JPS54129131A (en) 1978-03-27 1978-03-27 Antiimalignant tumor agent composition

Publications (2)

Publication Number Publication Date
JPS54129131A JPS54129131A (en) 1979-10-06
JPS6223723B2 true JPS6223723B2 (en, 2012) 1987-05-25

Family

ID=12452987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3583478A Granted JPS54129131A (en) 1978-03-27 1978-03-27 Antiimalignant tumor agent composition

Country Status (2)

Country Link
JP (1) JPS54129131A (en, 2012)
AU (1) AU520060B2 (en, 2012)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055493A1 (fr) * 1997-06-03 1998-12-10 Mori, Takahide Substances naturelles antitumorales ou antivirales et leur utilisation
US11484188B2 (en) 2019-03-07 2022-11-01 Fujifilm Corporation Endoscope

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005098A (en) * 1998-02-06 1999-12-21 Hoffmann-La Roche Inc. 5'deoxycytidine derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055493A1 (fr) * 1997-06-03 1998-12-10 Mori, Takahide Substances naturelles antitumorales ou antivirales et leur utilisation
US11484188B2 (en) 2019-03-07 2022-11-01 Fujifilm Corporation Endoscope

Also Published As

Publication number Publication date
AU4519679A (en) 1979-10-04
AU520060B2 (en) 1982-01-14
JPS54129131A (en) 1979-10-06

Similar Documents

Publication Publication Date Title
JP5357857B2 (ja) 抗ガン剤及びｄｎａ複製阻害剤
USRE37623E1 (en) Enzyme inhibitors, their synthesis, and methods for use
US6211166B1 (en) 5′-deoxy-cytidine derivative administration to treat solid tumors
JPH05506240A (ja) ５―ベンジルバルビツレート誘導体
JP2001131075A (ja) 抗ｈｉｖ剤
FI112601B (fi) Menetelmä 5-fluoriurasiilia sisältävän farmaseuttisen yhdistelmän valmistamiseksi, jolla on parantunut stabiilisuus urasiilireduktaasia vastaan
US4650801A (en) Anti-cancer compositions for delivering 5-fluorouracil
JPS6337766B2 (en, 2012)
JPS6223723B2 (en, 2012)
EP0290558A1 (en) ANTIFOLATE AGENT.
GB1570555A (en) Anti-cancer composition
JP2531952B2 (ja) フオスホリラ−ゼ阻害剤
JPS6223724B2 (en, 2012)
JPS6337787B2 (en, 2012)
JPH0120128B2 (en, 2012)
JPS6231689B2 (en, 2012)
JPS6130520A (ja) 抗腫瘍剤
JPS6213924B2 (en, 2012)
JPH06172365A (ja) １０−チアイソアロキサジン誘導体およびその用途
JPS6223725B2 (en, 2012)
JPS6257165B2 (en, 2012)
JPS5953885B2 (ja) 抗腫瘍剤組成物
JPS61109720A (ja) 抗腫瘍剤
JPS621371B2 (en, 2012)
JPS6312845B2 (en, 2012)